This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
OTC
HealthdirectFree Australian health advice you can count on.
EQ 50MG BASE, Tablet, extended release
INN: QUETIAPINE FUMARATE
Data updated: 2026-04-25
Available in:
🇩🇪🇬🇧🇷🇴
Form
TABLET, EXTENDED RELEASE
Dosage
EQ 50MG BASE
Route
ORAL
Storage
—
About This Product
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Manufacturer
CHEPLAPHARM ARZNEIMITTEL GMBH
ATC Code
N05AH04
Source
FDA_OB · 022047
(
ARTG
)
SEROQUEL XR is indicated for: Bipolar disorder - Maintenance treatment of bipolar 1 disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes. Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration). Treatment of acute mania associated with bipolar I disorder as monotherapy or incombination with lithium or sodium valproate. Efficacy of SEROQUEL XR in the treatment of bipolar disorder indications was established in part, on the basis of extrapolation from the established effectiveness of SEROQUEL. Schizophrenia - Treatment of schizophrenia, prevention of relapse and maintenance of clinical improvement during continuation therapy. Major depressive disorder (MDD)- Treatment of recurrent major depressive disorder in patients who are intolerant of, or who have an inadequate response to alternative therapies. Generalised anxiety disorder (GAD). Treatment of generalised anxiety disorder.
⚠️ Warnings
(
AHT
)
This medicine contains the active ingredients:
quetiapine
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on
medication safety for older people
.